Polysaccharides-mediated mitochondrial remodeling: role in chemotherapy resistance of gastrointestinal tumors.
Su Bu, Xinrui Zhou, Deyi Li et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examined the role of mitochondrial remodeling in chemotherapy resistance in gastrointestinal (GI) tumors and evaluated the potential of polysaccharides as therapeutic agents. The review synthesized evidence from 20 studies, indicating that polysaccharides may modulate chemotherapy responses through mechanisms such as metabolic remodeling and regulation of apoptosis. The findings highlight the need for further research to establish clinical applications.
Key findings
- Polysaccharides may modulate chemotherapy responses in GI tumors through mitochondrial-related mechanisms.
- Mechanisms include metabolic remodeling, regulation of the apoptotic threshold, and modulation of redox status.
- The review included 20 studies that supported the involvement of polysaccharides in chemotherapy resistance.
- Clinical translation is limited by heterogeneity in polysaccharide structure and insufficient standardization.
Why it matters
Understanding the mechanisms of chemotherapy resistance in GI cancers is crucial for developing effective treatments. Polysaccharides may offer a novel approach to enhance therapeutic responses, potentially improving patient outcomes in this challenging area of oncology.
What to keep in mind
Clinical translation is hindered by the heterogeneity of polysaccharide structures and limited human evidence.